These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2052328)

  • 21. Influence of selected tensides on the hydrocortisone concentration equilibrium balance in micelles and the dispersing center.
    Szcześniak M; Kubis AA
    Pharmazie; 2006 Apr; 61(4):316-7. PubMed ID: 16649545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Empty sella syndrome': a case of a patient with sodium succinate hydrocortisone allergy.
    Nucera E; Lombardo C; Aruanno A; Colagiovanni A; Buonomo A; de Pasquale T; Pecora V; Sabato V; Rizzi A; Pascolini L; Ricci AG; Schiavino D
    Eur J Endocrinol; 2011 Jan; 164(1):139-40. PubMed ID: 20961968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of side-effects and treatment on the experimental colitis in mice of a resin microcapsule-loading hydrocortisone sodium succinate.
    Dong K; Zhang H; Yan Y; Sun J; Dong Y; Wang K; Zhang L; Shi X; Xing J
    Drug Dev Ind Pharm; 2017 Mar; 43(3):448-457. PubMed ID: 27819157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled release of tetracycline I: In vitro studies with a trilaminate 2-hydroxyethyl methacrylate-methyl methacrylate system.
    Olanoff L; Koinis T; Anderson JM
    J Pharm Sci; 1979 Sep; 68(9):1147-50. PubMed ID: 501539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative approach based on artificial neural networks to study controlled drug release.
    Reis MA; Sinisterra RD; Belchior JC
    J Pharm Sci; 2004 Feb; 93(2):418-30. PubMed ID: 14705198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro study of gastrointestinal diffusion system using disopyramide phosphate.
    Jedras Z; Janicki S
    Pharmazie; 1987 Dec; 42(12):842-4. PubMed ID: 3444847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effect of human saliva on the output of fluoride from controlled-release devices.
    Adair SM; Whitford GM; Hanes CM
    Pediatr Dent; 1994; 16(6):410-2. PubMed ID: 7854946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of extended release mini-tablets using directly compressible grades of HPMC.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1690-7. PubMed ID: 23078551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new intraoral controlled fluoride release device.
    Altinova YB; Alaçam A; Aydin A; Sanisoglu SY
    Caries Res; 2005; 39(3):191-4. PubMed ID: 15914980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a dynamic dissolution/permeation model: Mutual influence of dissolution and barrier-flux under non-steady state conditions.
    Sironi D; Christensen M; Rosenberg J; Bauer-Brandl A; Brandl M
    Int J Pharm; 2017 Apr; 522(1-2):50-57. PubMed ID: 28263834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium acetate gastrointestinal diffusion system. Part 1: Lithium acetate single-unit gastrointestinal diffusion system: preparation and release rate studies.
    Janicki S; Jedras Z
    Pharmazie; 1990 Jan; 45(1):45-7. PubMed ID: 2333312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of colon targeted drug delivery systems for albendazole using kneading, extrusion and compaction technology.
    Emeje M; Nwabunike P; Isimi Y; Kunle O; Ofoefule S
    Yao Xue Xue Bao; 2009 Oct; 44(10):1152-8. PubMed ID: 20055141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics.
    Ichikawa M; Watanabe S; Miyake Y
    J Pharm Sci; 1991 Nov; 80(11):1062-6. PubMed ID: 1815057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a standardized dissolution test method for inhaled pharmaceutical formulations.
    Son YJ; McConville JT
    Int J Pharm; 2009 Dec; 382(1-2):15-22. PubMed ID: 19665533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride.
    Patel VM; Prajapati BG; Patel MM
    AAPS PharmSciTech; 2007 Mar; 8(1):22. PubMed ID: 17408221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets.
    Ceschel GC; Maffei P; Lombardi Borgia S; Ronchi C
    Drug Deliv; 2001; 8(3):161-71. PubMed ID: 11570597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.
    Li X; Jiang Q; Du L; Wang C; Chi Q
    Pharmazie; 2012 Aug; 67(8):695-700. PubMed ID: 22957434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of artificial saliva and calcium on fluoride output of controlled-release devices.
    Adair SM; Whitford GM; McKnight-Hanes C
    Caries Res; 1994; 28(1):28-34. PubMed ID: 8124694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.